Combination of SGLT2 inhibitor dapagliflozin and GLP-1 agonist liraglutide showed potential for enhanced cardio-renal protection through complementary mechanisms.
Key findingCombination of SGLT2 inhibitor dapagliflozin and GLP-1 agonist liraglutide showed potential for enha
What the researchers found
Combination of SGLT2 inhibitor dapagliflozin and GLP-1 agonist liraglutide showed potential for enhanced cardio-renal protection through complementary mechanisms.
Why it matters
These findings have significant implications for peptide-based therapeutic development and clinical practice.
The numbers in context
30 rats total: 6 controls, 24 diabetic rats split into 4 groups. High-fat diet for 4 weeks followed by single-dose streptozotocin to induce diabetes.
How the study worked
Study design and methodology detailed in the full publication.
Who was studied
Male rats with diet and streptozotocin-induced type 2 diabetes
What this study cannot tell us
Study-specific limitations discussed in the full publication. Results should be interpreted within the context of study design.
How to read the evidence
Evidence assessment based on study design detailed in publication.
When this study was published
Published in 2025. Current peptide therapeutic research.
The bigger picture
This study contributes to the expanding understanding of how peptide-based therapeutics can be applied across medical specialties.
Questions still open
- What are the long-term implications?
- How do these results compare to existing evidence?
- What further research is needed?
Common questions
What does this study mean for patients?
How reliable are these findings?
Read the original research
The Potential Effect of Dapagliflozin and Liraglutide in Attenuating Cardio-Renal Injuries in Diabetic Rats.
Journal of experimental pharmacology, 17, 467-484
Citation
Albanna, Adel Ali; Ibrahim, Doa'a Anwar; Shamsher, Amani Mohammed; Al-Shawia, Mojahed Ali; Halboup, Abdulsalam. (2025). The Potential Effect of Dapagliflozin and Liraglutide in Attenuating Cardio-Renal Injuries in Diabetic Rats.. Journal of experimental pharmacology, 17, 467-484. https://doi.org/10.2147/JEP.S522053